Search filters

List of works by Aron Goldhirsch

"Waiting and the waiting room: how do you experience them?" emotional implications and suggestions from patients with cancer.

scientific article

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

scientific article published on 16 February 2017

2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial

scientific article published on 18 July 2013

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

scientific article published in January 2007

A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases

scientific article published on 21 November 2013

A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer.

scientific article published on 13 May 2010

A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers

scientific article

A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer

scientific article published on 29 June 2012

Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials.

scientific article published on 04 April 2016

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

scientific article published on 16 October 2019

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial

scientific article

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

scientific article published on 26 November 2018

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.

scientific article published on 28 March 2016

Adjuvant chemotherapy (ECF regimen) for patients with gastric adenocarcinoma

scientific article published on 01 April 2007

Adjuvant chemotherapy in breast cancer: back to the future.

scientific article published in April 2003

Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.

scientific article published on 8 January 2008

Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.

scientific article published in December 2003

Adjuvant endocrine therapy in premenopausal women with operable breast cancer: understanding the issues.

scientific article published in April 2010

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

scientific article

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

scientific article

Adjuvant ovarian suppression in premenopausal breast cancer

scientific article

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial

scientific article published on 28 February 2013

Adjuvant systemic therapies for patients with breast cancer: endocrine responsiveness and effects of chemotherapy.

scientific article

Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: a systematic review of randomized controlled trials.

scientific article published on 27 April 2012

Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials.

scientific article published on 02 October 2013

Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer

scientific article published on 27 February 2010

Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI

scientific article published on 18 May 2007

An interview with Dr. Aron Goldhirsch

scientific article published in September 2002

Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.

scientific article

Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group.

scientific article published on 13 July 2007

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.

scientific article published on 19 January 2016

Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine.

scientific article published on 12 March 2015

Are there benefits in routine clinical practice of continuing trastuzumab after progression for metastatic breast cancer patients?

scientific article published in November 2012

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

scientific article published on 20 October 2011

Autologous fat transplantation in patients with breast cancer: "silencing" or "fueling" cancer recurrence?

scientific article published on 05 February 2011

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

scientific article published on 05 September 2018

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial

scientific article published on 11 March 2013

Best management of locally advanced inoperable breast cancer

scientific article

Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives

scientific article

Biopsy of liver metastasis for women with breast cancer: Impact on survival

article by Edoardo Botteri et al published June 2012 in The Breast

Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences

scientific article published on February 2014

Breast cancer in the elderly.

scientific article

Breast cancer in young women: climbing for progress in care and knowledge

scientific article published on September 2006

Breast cancer: Anastrozole and fulvestrant--combination to unlock efficacy

scientific article published on 04 September 2012

Breast cancer: why do women opt for contralateral prophylactic mastectomy?

scientific article published on 08 July 2014

Breast phyllodes tumor: a review of literature and a single center retrospective series analysis

scientific article published on 17 July 2013

CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial

scientific article published on 3 May 2015

CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial

scientific article published on 6 March 2012

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

article

Cardiac toxicity from systemic cancer therapy: a comprehensive review.

scientific article published on September 2010

Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.

scientific article published on 12 November 2007

Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.

scientific article

Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.

scientific article

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study

scientific article published on 13 February 2017

Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

scientific article

Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial

scientific article published on 08 December 2020

Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

scientific article

Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial

scientific article

Comparing Treatments Using Quality-Adjusted Survival: The Q-TWiST Method

Comparing aromatase inhibitors in the absence of clinical trial results can be misleading

scientific article published on 01 March 2007

Conservative surgery in patients with multifocal/multicentric breast cancer

scientific article published on 11 March 2008

Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

scientific article published on 01 March 2020

Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment

scientific article

Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial

scientific article published on 07 November 2020

Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results

scientific article published on 01 April 2003

Dendritic cell-based vaccines: clinical applications in breast cancer.

scientific article published on January 2014

Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.

scientific article published on August 2013

Different effectiveness of anticancer immunotherapy in men and women relies on sex-dimorphism of the immune system

scientific article published on 27 July 2018

Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer

scientific article published on 17 January 2013

Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials

scientific article published on 05 May 2008

Do Early Breast Cancer Patients with Only Sentinel Lymph Node Biopsy Experience Lower Psychological Morbidity Over Time? ⬇️

scientific article published on October 11, 2012

Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?

scientific article published in November 2014

Drug-induced QTc interval prolongation: a proposal towards an efficient and safe anticancer drug development.

scientific article

Drug-induced immune thrombocytopenia

ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer

scientific article published on 21 November 2015

Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93

scientific article published on 11 April 2007

Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence

scientific article published on 30 December 2019

Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case series

scientific article published on 12 April 2014

Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapy

scientific article published on 01 March 2020

Exemestane seems to stimulate tumour growth in men with prostate carcinoma

scientific article published in September 2003

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

scientific article published on 17 November 2017

Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer.

scientific article

From the maximum tolerable to the minimum effective treatment: The Umberto Veronesi's life commitment to breast cancer care.

scientific article published on 19 November 2016

Genomic aberrations and late recurrence in postmenopausal women with hormone receptor-positive early breast cancer: Results from the SOLE Trial

scientific article published on 20 October 2020

HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence

scientific article published on July 2016

HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17

scientific article published on 12 September 2007

Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome.

scientific article published on 24 October 2012

High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer.

scientific article published on 4 December 2013

Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients

scientific article

Immune approaches to the treatment of breast cancer, around the corner?

scientific article published on 25 February 2014

Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander".

scientific article published on 03 March 2014

Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.

scientific article published on 6 August 2011

Immunohistochemically defined subtypes and outcome of apocrine breast cancer

scientific article

Immunology and breast cancer: therapeutic cancer vaccines.

scientific article published on 13 August 2007

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial

scientific article published on 8 November 2016

Impact of autoimmune diseases on outcome of patients with early breast cancer.

scientific article published on 13 June 2016

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease

scientific article published on 9 June 2015

Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires--an Italian exploratory study

scientific article published on 17 November 2015

Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab ⬇️

scientific article published on February 16, 2012

Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy

scientific article

Intermittent Letrozole Administration as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer: A Biologic Study

scientific article published on 30 April 2015

Intrathecal chemotherapy in carcinomatous meningitis from breast cancer

scientific article published on September 2002

Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity

scientific article published on 7 October 2008

Invasive lobular breast cancer: subtypes and outcome

scientific article

Is Adjuvant Chemotherapy Useful for Women With Luminal A Breast Cancer? ⬇️

scientific article published on February 21, 2012

Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.

scientific article published on 25 October 2008

Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93

scientific article

Keeping faith with trial volunteers

scientific article published in Nature

Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?

scientific article published in March 2003

Lack of prognostic significance of “classic” lobular breast carcinoma: a matched, single institution series

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

scientific article

Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.

scientific article published on 10 March 2008

Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer.

scientific article published on 8 January 2011

Locoregional recurrence in patients with HER2 positive breast cancer

scientific article published in May 2013

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data

scientific article published on 10 September 2019

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.

scientific article

Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter

scientific article (publication date: October 2007)

Mediastinal lymphoadenopathy in a patient with breast cancer

scientific article published on 01 March 2002

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

scientific article

Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity

scientific article

Metronomic chemotherapy in elderly patients: do risks exceed benefits in some patients?

scientific article published on 01 January 2009

Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer.

scientific article

Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.

scientific article published on 6 December 2009

Molecular pathways: human leukocyte antigen G (HLA-G).

scientific article published on 29 July 2013

Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities

scientific article published on 23 October 2013

Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00.

scientific article published on 27 March 2018

Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial

scientific article published on 27 December 2018

Neoadjuvant chemotherapy for breast cancer: any progress?

scientific article

Neoadjuvant chemotherapy: not the best option in estrogen receptor-positive, HER2-negative, invasive classical lobular carcinoma of the breast?

scientific article published on 06 July 2010

Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancer

scientific article published on 16 July 2010

New criteria for selecting elderly patients for breast cancer adjuvant treatment studies

scientific article published on August 2007

No link between breast cancer and meningioma: results from a large monoinstitutional retrospective analysis

scientific article published on 28 October 2013

Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial

scientific article

Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report.

scientific article published on 25 July 2012

Outcome and Medial Presentation of Breast Cancer: European Institute of Oncology Experience.

scientific article published on 10 July 2015

Outcome of Immediate Breast Reconstruction in Patients With Nonendocrine-Responsive Breast Cancer: A Monoinstitutional Case-Control Study.

scientific article published on 24 March 2015

Outcome of male breast cancer: a matched single-institution series

scientific article published in March 2014

Outcomes of patients with breast cancer who present with ipsilateral supraclavicular or internal mammary lymph node metastases.

scientific article published on 27 September 2013

Overhauling the breast cancer overview: are subsets subversive?

scientific article published on 01 September 2002

Participation in clinical trials as viewed by the patient: understanding cultural and emotional aspects which influence choice.

scientific article published on 20 August 2008

Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression

scientific article published on 18 July 2007

Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features

scientific article published on 13 July 2010

Pathological features and survival outcomes of very young patients with early breast cancer: how much is "very young"?

scientific article published on 30 September 2013

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.

scientific article

Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.

scientific article published on 29 July 2013

Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century

scientific article published on 10 January 2009

Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer

scientific article published on 11 March 2011

Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient

scientific article published on August 2013

Phase II Study With Epirubicin, Cisplatin, and Infusional Fluorouracil Followed by Weekly Paclitaxel With Metronomic Cyclophosphamide as a Preoperative Treatment of Triple-Negative Breast Cancer

scientific article published on 18 March 2015

Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer

scientific article published in April 2002

Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancer.

scientific article published on December 2010

Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial

scientific article published on 06 February 2018

Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.

scientific article published on 22 October 2015

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

scientific article published on 29 January 2008

Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?

scientific article published on 4 February 2015

Pregnancy after breast cancer: if you wish, ma’am ⬇️

scientific article published on June 23, 2011

Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors

scientific article published in July 2008

Preoperative therapy with trastuzumab and oral vinorelbine (+/- endocrine therapy) in patients with HER2-positive breast cancer

scientific article published on 8 February 2010

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date

scientific article published on 30 January 2018

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

scientific article

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

scientific article published on 6 August 2007

Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study

scientific article

Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX ⬇️

scientific article published on November 5, 2012

Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.

scientific article published in October 2012

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

scientific article

QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation: a comprehensive review.

scientific article published on 27 June 2014

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

scientific article published on 10 April 2019

Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer

scientific article

Re: Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients with 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial

scientific article published on 28 August 2007

Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial

scientific article

Reply to Jeffrey Graham, Omar Abdel-Rahman, Toni K. Choueiri, and Daniel Y.C. Heng's Letter to the Editor re: Fabio Conforti, Laura Pala, Vincenzo Bagnardi, et al. Cancer Immunotherapy Efficacy and Patients' Sex: A Systematic Review and Meta-analysi

scientific article published on 14 September 2018

Reply to L. Moscetti

scientific article published on 17 January 2017

Response of extensive breast cancer skin metastases to rechallenge with trastuzumab together with low-dose chemotherapy and insulin

scientific article

Results of chest wall resection for recurrent or locally advanced breast malignancies.

scientific article published on 12 February 2007

Role of breast surgery in T1-3 breast cancer patients with synchronous bone metastases.

scientific article published on 15 February 2013

Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy

scientific article published in September 2008

Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial.

scientific article published on 25 January 2017

Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group

scientific article published on 04 December 2008

Sentinel lymph node biopsy in pregnant patients with breast cancer

scientific article published on 01 January 2010

Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the Microbiome

scientific article published on 28 December 2018

Sex as a predictor of response to cancer immunotherapy - Authors' reply

scientific article published on 01 August 2018

Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysis

scientific article published on 01 August 2019

Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression

scientific article published on 26 October 2013

Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.

scientific article published on 7 December 2007

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

scientific article published on 04 June 2018

Targeting the subtypes of breast cancer: rethinking investigational drugs

scientific article published on 10 January 2012

The Triple-Negative Subtype: New Ideas for the Poorest Prognosis Breast Cancer

scientific article published on 01 January 2011

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

scientific article published on 4 September 2011

The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control study

scientific article published on 16 December 2011

The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy

article

The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer

scientific article published on 09 April 2007

Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women.

scientific article

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care

scientific article

Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VII.

scientific article published on October 2016

Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy

scientific article published on 20 March 2010

Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.

scientific article

To switch or not to switch: implications of sequencing adjuvant endocrine therapy in patients with breast cancer

scientific article published on 10 July 2007

Topoisomerase IIα gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer

article

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

scientific article

Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience

scientific article published on 26 December 2015

Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence.

scientific article published on 23 May 2016

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

scientific article

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.

scientific article published on 25 February 2011

Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

scientific article published on 09 April 2020

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.

scientific article published on 02 July 2016

Vaccine immunotherapy in breast cancer treatment: promising, but still early.

scientific article published on September 2007

Weekly epirubicin in the treatment of gestational breast cancer (GBC).

scientific article published on 20 August 2008

Paulina is supported by:

About Paulina

Help